The biotech sector is witnessing a resurgence after facing challenges in recent years, with several indicators pointing towards a thawing of the ‘deep freeze’ that gripped the industry. Here’s a breakdown of the recent developments and reasons for optimism: In conclusion, the recent uptick in biotech activity, including IPOs, follow-on financing, and venture capital investment,Continue reading “Biotech Industry Shows Signs of Recovery”
